vimarsana.com

Page 45 - Dexcom Share News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Retirement Systems of Alabama Sells 26,111 Shares of DexCom, Inc (NASDAQ:DXCM)

Retirement Systems of Alabama trimmed its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 22.9% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,101 shares of the medical device company’s stock after selling 26,111 shares during the quarter. Retirement […]

DexCom (NASDAQ:DXCM) Given New $100 00 Price Target at JPMorgan Chase & Co

DexCom (NASDAQ:DXCM – Free Report) had its price objective decreased by JPMorgan Chase & Co. from $160.00 to $100.00 in a report issued on Tuesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical device company’s stock. Several other equities research analysts have also issued reports on the company. […]

Leerink Partnrs Reaffirms Outperform Rating for DexCom (NASDAQ:DXCM)

Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research report sent to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]

DexCom (NASDAQ:DXCM) Given Outperform Rating at Leerink Partnrs

Leerink Partnrs restated their outperform rating on shares of DexCom (NASDAQ:DXCM – Free Report) in a research note issued to investors on Monday, PriceTargets.com reports. Leerink Partnrs also issued estimates for DexCom’s Q3 2023 earnings at $0.37 EPS, Q4 2023 earnings at $0.42 EPS, Q1 2024 earnings at $0.30 EPS, Q2 2024 earnings at $0.39 […]

DexCom, Inc (NASDAQ:DXCM) Stake Trimmed by EFG Asset Management North America Corp

EFG Asset Management North America Corp. lessened its holdings in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 15.7% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 41,321 shares of the medical device company’s stock after selling […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.